{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:24:58Z","timestamp":1787005498824,"version":"build-2736575974"},"reference-count":68,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The standard treatment modality for high grade serous ovarian carcinoma (HGSOC), the most common and aggressive subtype of ovarian cancer, consists of surgery followed by chemotherapy, which is associated with major challenges including off-target effects and therapy resistance. Ferroptosis, a non-apoptotic regulated cell death program, has gained recent interest for its potential to effectively eliminate therapy-resistant cells. Leveraging ferroptosis, we report the development of an intrinsically therapeutic lipid-based nanoparticle platform through the incorporation of bioactive polyunsaturated fatty acid (PUFA)-containing vinyl ether-linked phospholipids, known as plasmalogens, into liposomes that encapsulate ferroptosis inducer RSL3 to effectively eliminate human OVCAR8 ovarian cancer cells. These bioactive lipids were chosen due to their ability to sensitize the cells toward ferroptosis, thus imparting on the nanocarriers a therapeutic role beyond their function as a delivery vehicle. The developed nanoparticle platform showed enhanced therapeutic efficacy compared to free RSL3 in OVCAR8 cells. In addition, by surface modification with hyaluronic acid (HA) through electrostatic layer-by-layer deposition, we further improved the therapeutic efficacy of the platform by increasing nanocarrier uptake in OVCAR8 cells. Further, we showed that the use of plasmalogen-containing nanocarriers for synergistic ferroptosis induction could be extended to nucleic acid cargo delivery via lipid nanoparticles (LNPs). Plasmalogen-containing LNPs that encapsulated small interfering RNA (siRNA) designed to downregulate expression of the gene responsible for ferroptotic evasion showed improved cancer cell cytotoxicity compared to the control LNPs without any plasmalogens. Overall, this integrated approach presents a novel strategy to tackle ovarian cancer, with the possibility of translation into an effective treatment approach for ovarian cancer patients who are not responsive to standard treatment modalities.<\/jats:p>","DOI":"10.1021\/acsbiomaterials.6c00687","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:16:18Z","timestamp":1785849378000},"page":"4278-4294","source":"Crossref","is-referenced-by-count":0,"title":["Inherently Therapeutic Plasmalogen-Based Nanoparticle Platform to Kill Ovarian Cancer Cells via Synergistic Ferroptosis Induction"],"prefix":"10.1021","volume":"12","author":[{"given":"Amartya","family":"Viravalli","sequence":"first","affiliation":[{"name":"University of Minnesota Twin Cities , , , ,","place":["Minneapolis, Minnesota, United States, 55455"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6654-4667","authenticated-orcid":true,"given":"Plinio D.","family":"Rosales","sequence":"additional","affiliation":[{"name":"University of Minnesota Twin Cities , , , ,","place":["Minneapolis, Minnesota, United States, 55455"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0395-4988","authenticated-orcid":true,"given":"Samira M.","family":"Azarin","sequence":"additional","affiliation":[{"name":"University of Minnesota Twin Cities , , , ,","place":["Minneapolis, Minnesota, United States, 55455"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3468-2033","authenticated-orcid":true,"given":"Natalie","family":"Boehnke","sequence":"additional","affiliation":[{"name":"University of Minnesota Twin Cities , , , ,","place":["Minneapolis, Minnesota, United States, 55455"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"9","key":"2026081717152716900_cit1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","article-title":"Clinical and Translational Advances in Ovarian Cancer Therapy","volume":"4","author":"Konstantinopoulos","year":"2023","journal-title":"Nat. Cancer"},{"issue":"12","key":"2026081717152716900_cit2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","article-title":"Heterogeneity and Treatment Landscape of Ovarian Carcinoma","volume":"20","author":"Veneziani","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"22","key":"2026081717152716900_cit3","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1158\/1078-0432.CCR-04-0683","article-title":"Recurrent Ovarian Cancer","volume":"10","author":"Herzog","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"10177","key":"2026081717152716900_cit4","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial Ovarian Cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"issue":"28","key":"2026081717152716900_cit5","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1038\/s41388-025-03448-3","article-title":"Exploring the Therapeutic Use and Outcome of Antibody-Drug Conjugates in Ovarian Cancer Treatment","volume":"44","author":"Narayana","year":"2025","journal-title":"Oncogene"},{"issue":"1","key":"2026081717152716900_cit6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrc.2016.113","article-title":"The Disparate Origins of Ovarian Cancers: Pathogenesis and Prevention Strategies","volume":"17","author":"Karnezis","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"S10","key":"2026081717152716900_cit7","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1002\/cncr.11345","article-title":"Pathology and Classification of Ovarian Tumors","volume":"97","author":"Chen","year":"2003","journal-title":"Cancer"},{"key":"2026081717152716900_cit8","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1097\/IGC.0000000000000223","article-title":"Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors","volume":"24","author":"Brown","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"6","key":"2026081717152716900_cit9","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.hoc.2018.07.007","article-title":"Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer","volume":"32","author":"Freimund","year":"2018","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"1","key":"2026081717152716900_cit10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of Ovarian Cancer: A Review","volume":"14","author":"Brett","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"2026081717152716900_cit11","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.966007","article-title":"Current Progress of Ferroptosis Study in Ovarian Cancer","volume":"9","author":"Tan","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"2026081717152716900_cit12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"3","key":"2026081717152716900_cit13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic Lethal Screening Identifies Compounds Activating Iron-Dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells","volume":"15","author":"Yang","year":"2008","journal-title":"Chem. Biol."},{"issue":"2","key":"2026081717152716900_cit14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"2","key":"2026081717152716900_cit15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00031.2024","article-title":"Ferroptosis: When Metabolism Meets Cell Death","volume":"105","author":"Zheng","year":"2025","journal-title":"Physiol. Rev."},{"issue":"1","key":"2026081717152716900_cit16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in Cancer Therapy: A Novel Approach to Reversing Drug Resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"issue":"7679","key":"2026081717152716900_cit17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-Tolerant Persister Cancer Cells Are Vulnerable to GPX4 Inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"issue":"34","key":"2026081717152716900_cit18","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","article-title":"Peroxidation of Polyunsaturated Fatty Acids by Lipoxygenases Drives Ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"2026081717152716900_cit19","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1016\/j.bbagen.2012.11.020","article-title":"Glutathione Peroxidases","volume":"1830","author":"Brigelius-Floh\u00e9","year":"2013","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"issue":"3","key":"2026081717152716900_cit20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"issue":"1\u20132","key":"2026081717152716900_cit21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of Ferroptotic Cancer Cell Death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"7664","key":"2026081717152716900_cit22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a Therapy-Resistant State of Cancer Cells on a Lipid Peroxidase Pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"issue":"5","key":"2026081717152716900_cit23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2024.03.019","article-title":"Ironing out the Role of Ferroptosis in Immunity","volume":"57","author":"Bell","year":"2024","journal-title":"Immunity"},{"key":"2026081717152716900_cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122395","article-title":"Ferroptosis-Enhanced Chemotherapy for Triple-Negative Breast Cancer with Magnetic Composite Nanoparticles","volume":"303","author":"Zhang","year":"2023","journal-title":"Biomaterials"},{"issue":"1","key":"2026081717152716900_cit25","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in Cancer: From Molecular Mechanisms to Therapeutic Strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"29","key":"2026081717152716900_cit26","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1038\/onc.2017.11","article-title":"Iron Addiction: A Novel Therapeutic Target in Ovarian Cancer","volume":"36","author":"Basuli","year":"2017","journal-title":"Oncogene"},{"issue":"7","key":"2026081717152716900_cit27","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1073\/pnas.89.7.3070","article-title":"High Resistance to Cisplatin in Human Ovarian Cancer Cell Lines Is Associated with Marked Increase of Glutathione Synthesis","volume":"89","author":"Godwin","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"2026081717152716900_cit28","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00139","article-title":"Mechanisms of Ferroptosis and Relations With Regulated Cell Death: A Review","volume":"10","author":"Lei","year":"2019","journal-title":"Front. Physiol."},{"issue":"1","key":"2026081717152716900_cit29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2017.7115","article-title":"GPx4, Lipid Peroxidation, and Cell Death: Discoveries, Rediscoveries, and Open Issues","volume":"29","author":"Maiorino","year":"2018","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"2026081717152716900_cit30","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-025-10067-x","article-title":"Intersection of Ferroptosis and Nanomaterials Brings Benefits to Breast Cancer","volume":"41","author":"Gao","year":"2025","journal-title":"Cell Biol. Toxicol."},{"issue":"5","key":"2026081717152716900_cit31","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2024.01.030","article-title":"Phospholipids with Two Polyunsaturated Fatty Acyl Tails Promote Ferroptosis","volume":"187","author":"Qiu","year":"2024","journal-title":"Cell"},{"issue":"1","key":"2026081717152716900_cit32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0891-5849(89)90102-0","article-title":"Oxygen Radical Chemistry of Polyunsaturated Fatty Acids","volume":"7","author":"Gardner","year":"1989","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"2026081717152716900_cit33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0163-7827(01)00003-0","article-title":"Plasmalogens: Biosynthesis and Functions","volume":"40","author":"Nagan","year":"2001","journal-title":"Prog. Lipid Res."},{"issue":"8","key":"2026081717152716900_cit34","doi-asserted-by":"publisher","DOI":"10.1096\/fba.2025-00010","article-title":"Plasmalogen as a Bioactive Lipid Drug: From Preclinical Research Challenges to Opportunities in Nanomedicine","volume":"7","author":"Wu","year":"2025","journal-title":"FASEB BioAdv."},{"issue":"1","key":"2026081717152716900_cit35","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-018-0685-9","article-title":"Plasmalogen Lipids: Functional Mechanism and Their Involvement in Gastrointestinal Cancer","volume":"17","author":"Messias","year":"2018","journal-title":"Lipids Health Dis."},{"issue":"7826","key":"2026081717152716900_cit36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","article-title":"Plasticity of Ether Lipids Promotes Ferroptosis Susceptibility and Evasion","volume":"585","author":"Zou","year":"2020","journal-title":"Nature"},{"issue":"1","key":"2026081717152716900_cit37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized Arachidonic and Adrenic PEs Navigate Cells to Ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"2026081717152716900_cit38","doi-asserted-by":"publisher","DOI":"10.1101\/2024.03.20.585922","article-title":"Ether Lipids Influence Cancer Cell Fate by Modulating Iron Uptake","author":"Henry","year":"2024","journal-title":"Cancer Biology"},{"issue":"19","key":"2026081717152716900_cit39","doi-asserted-by":"publisher","first-page":"11864","DOI":"10.1039\/d4nr04508d","article-title":"More than a Delivery System: The Evolving Role of Lipid-Based Nanoparticles","volume":"17","author":"Karmaker","year":"2025","journal-title":"Nanoscale"},{"issue":"2","key":"2026081717152716900_cit40","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1021\/acsnano.9b09213","article-title":"Tuning Nanoparticle Interactions with Ovarian Cancer through Layer-by-Layer Modification of Surface Chemistry","volume":"14","author":"Correa","year":"2020","journal-title":"ACS Nano"},{"issue":"21","key":"2026081717152716900_cit41","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.1016\/j.biomaterials.2013.03.059","article-title":"The Architecture and Biological Performance of Drug-Loaded LbL Nanoparticles","volume":"34","author":"Morton","year":"2013","journal-title":"Biomaterials"},{"issue":"7","key":"2026081717152716900_cit42","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/adfm.201504385","article-title":"Highly Scalable, Closed-Loop Synthesis of Drug-Loaded, Layer-by-Layer Nanoparticles","volume":"26","author":"Correa","year":"2016","journal-title":"Adv. Funct. Mater."},{"issue":"5","key":"2026081717152716900_cit43","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.1021\/acsnano.9b00792","article-title":"Solution Conditions Tune and Optimize Loading of Therapeutic Polyelectrolytes into Layer-by-Layer Functionalized Liposomes","volume":"13","author":"Correa","year":"2019","journal-title":"ACS Nano"},{"issue":"4","key":"2026081717152716900_cit44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/BF00123391","article-title":"Human Ovarian Tumour Cells Can Bind Hyaluronic Acid via Membrane CD44: A Possible Step in Peritoneal Metastasis","volume":"14","author":"Gardner","year":"1996","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"2026081717152716900_cit45","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3390\/ijms12021009","article-title":"Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis","volume":"12","author":"Ween","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"32","key":"2026081717152716900_cit46","doi-asserted-by":"publisher","first-page":"20614","DOI":"10.1021\/acsami.6b06823","article-title":"Multifunctional Hyaluronic Acid and Chondroitin Sulfate Nanoparticles: Impact of Glycosaminoglycan Presentation on Receptor Mediated Cellular Uptake and Immune Activation","volume":"8","author":"Oommen","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6604","key":"2026081717152716900_cit47","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm5551","article-title":"T. Massively Parallel Pooled Screening Reveals Genomic Determinants of Nanoparticle Delivery","volume":"377","author":"Boehnke","year":"2022","journal-title":"Science"},{"issue":"2","key":"2026081717152716900_cit48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0009-3084(71)90031-4","article-title":"Positions of Double Bonds in the Monounsaturated Alk-1-Enyl Groups from the Plasmalogens of Human Heart and Brain","volume":"6","author":"Panganamala","year":"1971","journal-title":"Chem. Phys. Lipids"},{"issue":"5938","key":"2026081717152716900_cit49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/306069a0","article-title":"Severe Plasmalogen Deficiency in Tissues of Infants without Peroxisomes (Zellweger Syndrome)","volume":"306","author":"Heymans","year":"1983","journal-title":"Nature"},{"issue":"11","key":"2026081717152716900_cit50","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1021\/acs.bioconjchem.2c00412","article-title":"Surface Presentation of Hyaluronic Acid Modulates Nanoparticle\u2013Cell Association","volume":"33","author":"Deiss-Yehiely","year":"2022","journal-title":"Bioconjug. Chem."},{"issue":"1","key":"2026081717152716900_cit51","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05477-8","article-title":"Cholesterol Mediated Ferroptosis Suppression Reveals Essential Roles of Coenzyme Q and Squalene","volume":"6","author":"Sun","year":"2023","journal-title":"Commun. Biol."},{"issue":"7998","key":"2026081717152716900_cit52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","article-title":"7-Dehydrocholesterol Is an Endogenous Suppressor of Ferroptosis","volume":"626","author":"Freitas","year":"2024","journal-title":"Nature"},{"issue":"6","key":"2026081717152716900_cit53","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomed."},{"issue":"7","key":"2026081717152716900_cit54","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.devcel.2025.02.004","article-title":"Mechanisms of Ferroptosis Sensitization and Resistance","volume":"60","author":"Lee","year":"2025","journal-title":"Dev. Cell"},{"key":"2026081717152716900_cit55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/B978-0-12-800047-2.00007-3","volume-title":"The Membranes of Cells","author":"Yeagle","year":"2016"},{"issue":"5","key":"2026081717152716900_cit56","doi-asserted-by":"publisher","DOI":"10.3390\/biom13050730","article-title":"Plasmalogens: Free Radical Reactivity and Identification of Trans Isomers Relevant to Biological Membranes","volume":"13","author":"Ferreri","year":"2023","journal-title":"Biomolecules"},{"issue":"11","key":"2026081717152716900_cit57","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004747","article-title":"Lipid Polymorphisms and Membrane Shape","volume":"3","author":"Frolov","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2026081717152716900_cit58","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2013.00494","article-title":"Importance of the Hexagonal Lipid Phase in Biological Membrane Organization","volume":"4","author":"Jouhet","year":"2013","journal-title":"Front. Plant Sci."},{"issue":"2","key":"2026081717152716900_cit59","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10429","article-title":"Synergistic Combination Therapy Delivered via Layer-by-layer Nanoparticles Induces Solid Tumor Regression of Ovarian Cancer","volume":"8","author":"Kong","year":"2023","journal-title":"Bioeng. Transl. Med."},{"issue":"7","key":"2026081717152716900_cit60","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1002\/ange.201911762","article-title":"Theranostic Layer-by-Layer Nanoparticles for Simultaneous Tumor Detection and Gene Silencing","volume":"132","author":"Boehnke","year":"2020","journal-title":"Angew. Chem."},{"key":"2026081717152716900_cit61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114365","article-title":"Cell-Specific mRNA Delivery via Nanobody-Functionalized Lipid Nanoparticles","volume":"388","author":"Chen","year":"2025","journal-title":"J. Controlled Release"},{"issue":"8","key":"2026081717152716900_cit62","doi-asserted-by":"publisher","DOI":"10.1002\/smsc.202300084","article-title":"Precision Localization of Lipid-Based Nanoparticles by Dual-Fluorescent Labeling for Accurate and High-Resolution Imaging in Living Cells","volume":"3","author":"Huang","year":"2023","journal-title":"Small Sci."},{"key":"2026081717152716900_cit63","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102168","article-title":"SPL-108 Mitigates Metastasis and Chemoresistance in Tubo-Ovarian Carcinoma","volume":"51","author":"Lara","year":"2025","journal-title":"Transl. Oncol."},{"issue":"2","key":"2026081717152716900_cit64","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108935","article-title":"Inhibition of CD44 Suppresses the Formation of Fibrotic Scar after Spinal Cord Injury via the JAK2\/STAT3 Signaling Pathway","volume":"27","author":"Guo","year":"2024","journal-title":"iScience"},{"issue":"12","key":"2026081717152716900_cit65","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro Story and the Clinical Translation of Nanomedicines Containing Nucleic Acid-Based Drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"2026081717152716900_cit66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"2026081717152716900_cit67","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40120-020-00208-1","article-title":"A Review of Patisiran (ONPATTRO) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis","volume":"9","author":"Urits","year":"2020","journal-title":"Neurol. Ther."},{"issue":"4","key":"2026081717152716900_cit68","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1039\/D5NR03734D","article-title":"A FRET-Based Toolkit for Quantifying Lipid Incorporation into Nanoparticles","volume":"18","author":"Rosales","year":"2026","journal-title":"Nanoscale"}],"container-title":["ACS Biomaterials Science &amp; Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsbiomaterials.6c00687","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/abseba\/article-pdf\/12\/8\/4278\/66475434\/ab-2026-00687s.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/abseba\/article-pdf\/12\/8\/4278\/66475434\/ab-2026-00687s.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:36:33Z","timestamp":1787002593000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/abseba\/article\/12\/8\/4278\/5236416\/Inherently-Therapeutic-Plasmalogen-Based"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,7,29]]},"published-print":{"date-parts":[[2026,8,10]]}},"URL":"https:\/\/doi.org\/10.1021\/acsbiomaterials.6c00687","relation":{},"ISSN":["2373-9878"],"issn-type":[{"value":"2373-9878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}